Vanberra Signal

Lantern Pharma

Curated by Signal

Developing drug and companion diagnostics for multi-drug resistant cancers

Overview

Developing drug and companion diagnostics for multi-drug resistant cancers. Its approach is to biomarker-biased genetic screening to identify and treat patients that would benefit most from our drugs. Its lead candidate is Irovfulven-1, a new class of anti-tumor agents to treat multi-drug-resistant cancers.

Key facts

Founded
2013

Business model

Contact

Open roles

4 roles
  • Precision Oncology Clinical Trial Coordinator

    Plano, TX · On-site · Volunteer

  • Bio-Curation Scientist

    Bengaluru, Karnataka, India · On-site · Volunteer

  • Bio-Curator / Biocuration Scientist

    Bengaluru, Karnataka, India · On-site · Temporary

+ 1 more open role on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of genetic testing for cats

    Life Sciences TechnologyMountain View, United States
  • A wellness brand focused on supporting women's hormonal health

    Life Sciences TechnologyIrving, United States
  • Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration

    Life Sciences TechnologyWaltham, United States

About Lantern Pharma

What does Lantern Pharma do?

Developing drug and companion diagnostics for multi-drug resistant cancers.

Where is Lantern Pharma headquartered?

Lantern Pharma is headquartered in Dallas, United States.

When was Lantern Pharma founded?

Lantern Pharma was founded in 2013.

Which sector is Lantern Pharma in?

Lantern Pharma operates in Life Sciences Technology.

Who are Lantern Pharma's competitors?

Companies similar to Lantern Pharma include Basepaws, Milamend, and Olaris.

Is Lantern Pharma hiring?

Yes. Lantern Pharma has 4 open roles listed on Vanberra Signal.